Please provide your email address to receive an email when new articles are posted on . The photopneumatic device improved acne in 66.7% of patients in this 7-week trial. Improvements were seen across ...
Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
The first step in controlling acne is understanding that it is a medical condition influenced by multiple factors, including ...
Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Verywell Health on MSN
Doxycycline for Acne: Everything to Know
Medically reviewed by William Truswell, MD Key Takeaways Doxycycline is often used for treating moderate to severe inflammatory acne. Doxycycline may cause side effects like stomach upset and light ...
Longer acne antibiotic duration increases recurrence and resistance without added benefit. Learn more about optimal treatment ...
Among nearly 20 different agents and treatment combinations, topical triple-agent fixed-dose combination (FDC) gel emerged as the most efficacious for moderate-to-severe acne. Researchers who ...
(RTTNews) - Ascletis Pharma Inc. (HKEX: 1672) today announced positive topline results from its Phase 3 study for Denifanstat, a once-daily oral fatty acid synthase (FASN) inhibitor for ...
Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. In a clinical trial, ...
SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and ...
The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results